Press Releases Belite Bio, Inc

Equities

BLTE

US07782B1044

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
40.93 ^USD	+2.97%		+18.71%	-10.54%

Apr. 26	Belite Bio Unveils Plan to Offer 651,380 American Depository Shares	MT
Mar. 22	Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Belite Bio Announces $25 Million Registered Direct Offering	Apr. 25	GL
Belite Bio : Initiates Stargardt Disease Clinical Trial in Japan	Apr. 22	PU
Belite Bio : Announces MHRA Submission of Tinlarebant for Stargardt Disease Clinical Trial in the United Kingdom	Apr. 18	PU
Belite Bio : Submits US IND Amendment to Initiate a Phase 2/3 Clinical Trial of Tinlarebant in Stargardt Disease	Mar. 25	PU
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan	Mar. 22	GL
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website	Mar. 11	GL
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 11	GL
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results	Mar. 06	GL
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results	Mar. 06	AQ
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference	Mar. 04	GL
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference	Mar. 04	AQ
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 07	GL
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 07	AQ
Belite Bio : Receives Approval to Initiate Tinlarebant Phase 3 Clinical Trial for GA in China	Dec. 27	PU
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference	Nov. 30	GL
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference	Nov. 30	AQ
Belite Bio to Participate in the BTIG Ophthalmology Day	Nov. 20	GL
Belite Bio to Participate in the BTIG Ophthalmology Day	Nov. 20	AQ
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results	Nov. 13	GL
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results	Nov. 07	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Belite Bio, Inc

Equities

BLTE

US07782B1044

Press Releases

Filters